Deep Brain Stimulation for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to learn how brain signals are related to freezing of gait (FOG) and balance problems in Parkinson's disease (PD) and to study how different deep brain stimulation (DBS) settings may affect these symptoms.
Who Is on the Research Team?
Jay L Alberts, PhD
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for people diagnosed with Parkinson's disease who experience balance problems or freezing while walking. Participants should be able to walk and may already have a deep brain stimulator implanted.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cleveland Clinic Stair Ambulation and Functional Evaluation of Gait (SAFE-Gait)
- Moving Overground in a Virtual Environment (MOVE)
- Multiple Deep Brain Stimulation (DBS) Conditions
Trial Overview
Researchers are studying how different settings of deep brain stimulation (DBS) affect walking and balance in Parkinson’s disease, using tasks like moving in virtual environments and stair-walking evaluations.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All participants undergo repeated assessments under multiple deep brain stimulation (DBS) conditions in a randomized order. Each participant serves as their own control and completes testing under clinically optimized stimulation, as well as alternative stimulation paradigms. An additional baseline condition without stimulation is performed prior to randomized testing. Assessments include walking and balance tasks performed in a virtual reality environment designed to simulate real-world gait challenges, as well as stair ambulation and functional mobility tasks. Neural activity is recorded from the implanted DBS device and synchronized with biomechanical and kinematic data collected during task performance. This design enables within-subject comparisons of neural activity and gait performance across stimulation conditions.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.